Symbiosis Pharmaceutical Services


Symbiosis Pharmaceutical Services is a leading provider of GMP sterile fill-finish manufacturing services, supporting clinical and small-scale commercial production of biologics, small molecules, and advanced therapeutics. Established in 2011, the company aims to accelerate drug development timelines with rapid access to manufacturing slots, operational flexibility, and tailored process solutions. Recognized with a King's Award for Enterprise, Symbiosis is committed to service excellence, innovation, and building long-term client relationships.

Industries

biopharma
biotechnology
manufacturing

Nr. of Employees

medium (51-250)

Symbiosis Pharmaceutical Services


Products

Clinical-scale GMP manufacturing suites

Small-scale GMP manufacturing suites for clinical trial supply, including aseptic filling, analytical support and validation capabilities.

Commercial-scale aseptic filling capability (small volumes)

MHRA-licensed small-scale commercial aseptic filling for licensed biologic and small molecule products, supporting bulk volumes under 100 L and batch sizes up to ~3000 vials.


Services

Aseptic filling / sterile fill-finish

GMP aseptic filling of liquid and lyophilised parenteral products for clinical and small-scale commercial supply.

Bulk lyophilisation

Bulk freeze-drying services including loading and execution of lyophilisation campaigns for GMP material.

Drug product testing (analytical services)

Analytical testing to support GMP release and quality control of drug products.

Clinical labelling and packaging

Preparation, labelling and packaging of investigational medicinal products for clinical trials.

Qualified Person (QP) release and regulatory support

QP services for batch certification and regulatory support for product release and licensing.

Pharmaceutical product development and tech transfer

Process development, scale-up support and transfer of processes to GMP manufacturing including validation and PPQ support.

View All Services

Expertise Areas

  • Aseptic fill-finish for clinical and small commercial supply
  • Lyophilisation and freeze-drying processes
  • Advanced therapy (viral vector) and ATMP manufacturing
  • RNA/oligonucleotide formulation and fill-finish
  • Show More (6)

Key Technologies

  • Aseptic filling systems
  • Bulk lyophilisation (freeze-drying)
  • BSL-2 containment suites
  • Viral vector manufacture and handling
  • Show More (6)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.